hunterdon pharmaceut inc said form joint ventur with and develop c31g substanc may use treatment prevent plaqu substanc test pre clinic trial univers pennsylvania also has use anti fungal anti bacteri agent compani said said chesapeak biolog privat compani own pct ventur michael pct while hold remain interest and patent for c31g reuter 